These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 752250)

  • 1. Growth hormone in blood plasma of patients with liver cirrhosis.
    Kasperska-Czyzykowa T; Rogala H
    Acta Med Pol; 1978; 19(4):485-92. PubMed ID: 752250
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum insulin and growth hormone during glucose loading in liver cirrhosis].
    Schatz H; Paumgartner G; Brunner H; Höfer R; Grabner G
    Wien Z Inn Med; 1971; 52(1):41-6. PubMed ID: 5540818
    [No Abstract]   [Full Text] [Related]  

  • 3. [Plasma insulin and GH during oral glucose load in liver cirrhosis].
    Greco AV; Ghirlanda G; Altomonte L; Manna R; Rebuzzi AG
    Minerva Med; 1976 Jul; 67(35):2266-72. PubMed ID: 951048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum glucose, insulin, and growth hormone in chronic hepatic cirrhosis.
    Samaan NA; Stone DB; Eckhardt RD
    Arch Intern Med; 1969 Aug; 124(2):149-52. PubMed ID: 5797073
    [No Abstract]   [Full Text] [Related]  

  • 5. [Measurement of plasma insulin and growth hormone after oral glucose tolerance test in patients with alcoholic cirrhosis].
    Descos L; M'Bendi S; Sassolas G; Audigier JC; Sidiqian N; Faure A; Bizollon CA
    Arch Fr Mal App Dig; 1974; 63(1):17-24. PubMed ID: 4441222
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in carbohydrate metabolism in hepatic cirrhosis].
    Conde Yagüe R; Gutiérrez-Cortines Corral MD; Ledesma Castaño F; González Coterillo T; Ortiz Ortiz M; Ramos Fernández R
    Rev Clin Esp; 1985 Sep; 177(4):160-4. PubMed ID: 3906788
    [No Abstract]   [Full Text] [Related]  

  • 7. [Behavior of plasma/insulin, somatropin and NEFA after intravenous administration of tolbutamide in hepatic cirrhosis].
    Greco AV; Ghirlanda G; Rebuzzi A; Altomonte L; Manna R
    Minerva Med; 1976 Nov; 67(54):3525-32. PubMed ID: 995300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone levels and chronic liver cirrhosis.
    Toccafondi R; Maioli M; Palmas S
    Riv Crit Clin Med; 1970; 70(1):120-5. PubMed ID: 5527338
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes in plasma insulin and growth hormone after intravenous glucagon in hepatic cirrhosis].
    Ghirlanda G; Manna R; Rebuzzi A; Altomonte L; Greco AV
    Minerva Med; 1976 Oct; 67(49):3187-92. PubMed ID: 995278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Behavior of plasma IRI, HGH and cortisol after administration of levodopa in patients with hepatic cirrhosis].
    Palazzuoli V; Gragnoli G; Favilli R; Tanganelli I; Migliarese G
    Boll Soc Ital Biol Sper; 1976 May; 52(9):630-5. PubMed ID: 949450
    [No Abstract]   [Full Text] [Related]  

  • 11. Insulin and growth hormone response to an oral glucose load in Ugandan hepatocellular carcinoma patients.
    Primack A; Kajubi S
    East Afr Med J; 1974 Aug; 51(8):574-8. PubMed ID: 4371198
    [No Abstract]   [Full Text] [Related]  

  • 12. [Disturbances of carbohydrate regulation in hepatic lesions].
    Magnenat P
    Helv Med Acta; 1970 Dec; 35(5):354-62. PubMed ID: 5501843
    [No Abstract]   [Full Text] [Related]  

  • 13. Cirrhosis and diabetes. V. Serum human growth hormone levels in Laennec's cirrhosis.
    Conn HO; Daughaday WH
    J Lab Clin Med; 1970 Oct; 76(4):678-88. PubMed ID: 5458029
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma insulin response to oral glucose in liver cirrhosis.
    Toccafondi R; Palmas S; Maioli M
    Riv Crit Clin Med; 1970; 70(1):110-9. PubMed ID: 5527337
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in hydrocarbon metabolism in hepatic cirrhosis. VI. HGH].
    Santolaria Fernández F; González García C; González Reimers E; Pérez Labajos P; Jorge Hernández J; Batista López N; Hernández Nieto L; Bueno Gómez J
    Rev Esp Enferm Apar Dig; 1983 Jun; 63(6):525-33. PubMed ID: 6878841
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dynamics of concentration of insulin and growth hormone in blood serum in chronic liver diseases].
    Shlimovich PB; Sokolov IaA; Moskvichev AM
    Klin Med (Mosk); 1976 Jun; 54(6):90-5. PubMed ID: 972523
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes in plasma nonesterified fatty acids and glycerol during an induced hyperglycemia test by intravenous route in alcoholic and hemochromatotic cirrhosis].
    Poupon R; Simon M; Lenoir P; Bourel M
    Sem Hop; 1972 Jun; 48(29):2105-12. PubMed ID: 4343039
    [No Abstract]   [Full Text] [Related]  

  • 18. Glucose intolerance and insulin resistance in patients with liver disease. II. A study of etiologic factors and evaluation of insulin actions.
    Collins JR; Lacy WW; Stiel JN; Crofford OB
    Arch Intern Med; 1970 Oct; 126(4):608-14. PubMed ID: 5506964
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diabetes mellitus secondary to liver diseases. A review (author's transl)].
    Guillon J; Charbonnel B
    Diabete Metab; 1975 Sep; 1(3):191-9. PubMed ID: 791727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Levels of glucose, insulin and somatotropin hormone in patients with hyperbilirubinemia during the oral glucose tolerance test].
    Weber P; Martínek K; Kolácný I; Cechácek Z
    Vnitr Lek; 1987 Jul; 33(7):593-600. PubMed ID: 3310389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.